Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""neuroleptic"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 7864
Tytuł:
The role of antipsychotics and other drugs on the development and progression of neuroleptic malignant syndrome.
Autorzy:
Kyotani Y; Department of Pharmacology, Nara Medical University School of Medicine, 840 Shijo-Cho, Kashihara, Nara, 634-8521, Japan. .
Zhao J; Department of Pharmacology, Nara Medical University School of Medicine, 840 Shijo-Cho, Kashihara, Nara, 634-8521, Japan.
Nakahira K; Department of Pharmacology, Nara Medical University School of Medicine, 840 Shijo-Cho, Kashihara, Nara, 634-8521, Japan.
Yoshizumi M; Department of Pharmacology, Nara Medical University School of Medicine, 840 Shijo-Cho, Kashihara, Nara, 634-8521, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Oct 27; Vol. 13 (1), pp. 18459. Date of Electronic Publication: 2023 Oct 27.
Typ publikacji:
Journal Article
MeSH Terms:
Antipsychotic Agents*/adverse effects
Neuroleptic Malignant Syndrome*/etiology
Neuroleptic Malignant Syndrome*/drug therapy
Psychotic Disorders*/drug therapy
Drug-Related Side Effects and Adverse Reactions*/complications
Humans ; Drug Interactions
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Fluorouracil-induced leukoencephalopathy mimicking neuroleptic malignant syndrome: a case report.
Autorzy:
Hemachudha P; Thai Red Cross Emerging Infectious Diseases Health Science Centre, World Health Organization Collaborating Centre for Research and Training on Viral Zoonoses, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand. .; Division of Neurology, Department of Medicine, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand. .
Rattanawong W; Division of Neurology, Department of Medicine, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand.; Department of Medicine, Faculty of Medicine, King Mongkut's Institute of Technology Ladkrabang, Bangkok, Thailand.
Pongpitakmetha T; Division of Neurology, Department of Medicine, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand.; Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand.; Chula Neuroscience Center, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand.
Phuenpathom W; Division of Neurology, Department of Medicine, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand.; Chula Neuroscience Center, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand.; Chulalongkorn Center of Excellence for Parkinson's Disease and Related Disorders, Chulalongkorn University Hospital, Bangkok, 10330, Thailand.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2023 Mar 08; Vol. 17 (1), pp. 86. Date of Electronic Publication: 2023 Mar 08.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Neuroleptic Malignant Syndrome*/diagnosis
Neuroleptic Malignant Syndrome*/etiology
Colonic Neoplasms*/drug therapy
Thiamine Deficiency*
Leukoencephalopathies*/chemically induced
Leukoencephalopathies*/diagnostic imaging
Humans ; Male ; Aged ; Fluorouracil/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The management challenges of a case with Flupentixol-induced neuroleptic malignant syndrome.
Autorzy:
Elyasi F; Sexual and Reproductive Health Research Center, Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran.; Department of Psychiatry, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Sadati S; Department of Psychiatry, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.; Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Heydari F; Department of Anesthesiology and Critical Care Medicine, Imam Khomeini Hospital, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Pokaż więcej
Źródło:
Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2023 Mar; Vol. 43 (1), pp. 154-159. Date of Electronic Publication: 2022 Dec 30.
Typ publikacji:
Case Reports
MeSH Terms:
Neuroleptic Malignant Syndrome*/diagnosis
Neuroleptic Malignant Syndrome*/drug therapy
Neuroleptic Malignant Syndrome*/etiology
Antipsychotic Agents*/adverse effects
Psychotic Disorders*/drug therapy
Male ; Humans ; Middle Aged ; Flupenthixol/therapeutic use ; Bromocriptine/therapeutic use
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Multidisciplinary collaboration in diagnosis and treatment of neuroleptic malignant syndrome complicated with pneumonia: report of three cases.
Autorzy:
Zhao H; The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, 611731, China.; The Second Internal Medicine Department, the Fourth People's Hospital of Chengdu, Chengdu, 610036, China.
Lu S; The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, 611731, China.; The Second Internal Medicine Department, the Fourth People's Hospital of Chengdu, Chengdu, 610036, China.
Li X; The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, 611731, China.; The Second Internal Medicine Department, the Fourth People's Hospital of Chengdu, Chengdu, 610036, China.
Huang P; The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, 611731, China.; The Second Internal Medicine Department, the Fourth People's Hospital of Chengdu, Chengdu, 610036, China.
Wang H; The Second Internal Medicine Department, the Fourth People's Hospital of Chengdu, Chengdu, 610036, China. .
Lu F; The Second Internal Medicine Department, the Fourth People's Hospital of Chengdu, Chengdu, 610036, China. fengmei_.
Pokaż więcej
Źródło:
Diagnostic pathology [Diagn Pathol] 2022 Nov 09; Vol. 17 (1), pp. 89. Date of Electronic Publication: 2022 Nov 09.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Neuroleptic Malignant Syndrome*/diagnosis
Neuroleptic Malignant Syndrome*/therapy
Neuroleptic Malignant Syndrome*/etiology
Antipsychotic Agents*/adverse effects
Rhabdomyolysis*/complications
Rhabdomyolysis*/drug therapy
Pneumonia*/complications
Pneumonia*/diagnosis
Pneumonia*/drug therapy
Adult ; Humans ; Female
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Muscle magnetic resonance imaging abnormality in neuroleptic malignant syndrome: a case report.
Autorzy:
Kakinuma Y; Department of Internal Medicine, Fujiyoshida Municipal Medical Center, Yamanashi, Japan.
Amano R; Department of Internal Medicine, Fujiyoshida Municipal Medical Center, Yamanashi, Japan. .
Ishida A; Department of Internal Medicine, Fujiyoshida Municipal Medical Center, Yamanashi, Japan.
Nishino I; Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
Taki K; Department of Internal Medicine, Fujiyoshida Municipal Medical Center, Yamanashi, Japan.
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2022 Oct 29; Vol. 22 (1), pp. 396. Date of Electronic Publication: 2022 Oct 29.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Antipsychotic Agents*/adverse effects
Neuroleptic Malignant Syndrome*/diagnostic imaging
Neuroleptic Malignant Syndrome*/etiology
Female ; Humans ; Contrast Media ; Creatine Kinase ; Gadolinium ; Inflammation/complications ; Magnetic Resonance Imaging ; Muscles ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Neuroleptic malignant syndrome associated with acute organophosphate poisoning: Case report
Autorzy:
Angulo NY; Toxicología Clínica y Farmacovigilancia, IPS Universitaria Clínica León XIII, Medellín, Colombia. .
Castaño PA; Toxicología Clínica y Farmacovigilancia, IPS Universitaria Clínica León XIII, Medellín, Colombia. .
Gómez CC; Sección de Medicina de Urgencias, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia. .
Quintero S; Sección de Medicina de Urgencias, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia. .
Pokaż więcej
Transliterated Title:
Síndrome neuroléptico maligno asociado con intoxicación aguda por un organofosforado: reporte de caso.
Źródło:
Biomedica : revista del Instituto Nacional de Salud [Biomedica] 2022 Sep 02; Vol. 42 (3), pp. 445-449. Date of Electronic Publication: 2022 Sep 02.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Antipsychotic Agents*/adverse effects
Chlorpyrifos*/therapeutic use
Neuroleptic Malignant Syndrome*/diagnosis
Neuroleptic Malignant Syndrome*/etiology
Neuroleptic Malignant Syndrome*/therapy
Organophosphate Poisoning*/complications
Bromocriptine/therapeutic use ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Neuroleptic malignant syndrome in a case of extra-pontine myelinolysis: On the horns of dilemma.
Autorzy:
Arora U; Department of Medicine, All India Institute of Medical Sciences, Delhi, India.
Goel A; Department of Medicine, All India Institute of Medical Sciences, Delhi, India.
Ray A; Department of Medicine, All India Institute of Medical Sciences, Delhi, India.
Vikram NK; Department of Medicine, All India Institute of Medical Sciences, Delhi, India.
Pokaż więcej
Źródło:
Drug discoveries & therapeutics [Drug Discov Ther] 2022 Jul 20; Vol. 16 (3), pp. 145-147. Date of Electronic Publication: 2022 Jun 25.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Hyponatremia*/chemically induced
Myelinolysis, Central Pontine*/chemically induced
Myelinolysis, Central Pontine*/diagnostic imaging
Neuroleptic Malignant Syndrome*/diagnosis
Neuroleptic Malignant Syndrome*/etiology
Humans ; Magnetic Resonance Imaging/methods ; Male ; Middle Aged ; Sodium
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Atypical Neuroleptic Malignant Syndrome: Case Reports and Diagnostic Challenges.
Autorzy:
Szota AM; Department of Psychiatry, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland.
Radajewska I; Department of Psychiatry, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland.
Araszkiewicz AS; Department of Psychiatry, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland.
Pokaż więcej
Źródło:
Journal of psychoactive drugs [J Psychoactive Drugs] 2022 Jul-Aug; Vol. 54 (3), pp. 284-293. Date of Electronic Publication: 2021 Aug 02.
Typ publikacji:
Case Reports; Journal Article; Review
MeSH Terms:
Antipsychotic Agents*/adverse effects
Clozapine*/adverse effects
Neuroleptic Malignant Syndrome*/diagnosis
Neuroleptic Malignant Syndrome*/drug therapy
Neuroleptic Malignant Syndrome*/etiology
Aripiprazole/adverse effects ; Humans ; Male ; Muscle Rigidity/chemically induced ; Muscle Rigidity/complications ; Muscle Rigidity/drug therapy ; Olanzapine ; Quetiapine Fumarate/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Neuroleptic Malignant Syndrome with Adrenal Insufficiency After BNT162b2 COVID-19 Vaccination in a Man Taking Valproate: A Case Report.
Autorzy:
Mizuno T; Department of Nephrology, Tokyo Yamate Medical Center, Tokyo, Japan.
Takahashi R; Department of Nephrology, Tokyo Yamate Medical Center, Tokyo, Japan.
Kamiyama T; Department of Nephrology, Tokyo Yamate Medical Center, Tokyo, Japan.
Suzuki A; Department of Nephrology, Tokyo Yamate Medical Center, Tokyo, Japan.
Suzuki M; Department of Nephrology, Tokyo Yamate Medical Center, Tokyo, Japan.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2022 May 06; Vol. 23, pp. e936217. Date of Electronic Publication: 2022 May 06.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Adrenal Insufficiency*/chemically induced
Adrenal Insufficiency*/complications
BNT162 Vaccine*/adverse effects
COVID-19*/prevention & control
Neuroleptic Malignant Syndrome*/diagnosis
Neuroleptic Malignant Syndrome*/etiology
Neuroleptic Malignant Syndrome*/therapy
Adrenocorticotropic Hormone ; Bromocriptine/therapeutic use ; Dantrolene/therapeutic use ; Humans ; Hydrocortisone/therapeutic use ; Male ; Middle Aged ; Vaccination/adverse effects ; Valproic Acid/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Neuroleptic malignant-like syndrome associated multiple system atrophy: report on three cases.
Autorzy:
Lin Y; Department of Geriatric Medicine and Shandong Key Laboratory of Cardiovascular Proteomics, Qilu Hospital, Cheeloo College of Medicine, Shandong University, No. 107 West Wenhua Road, Jinan, 250012, Shandong, China.
Ma L; Department of Geriatric Medicine and Shandong Key Laboratory of Cardiovascular Proteomics, Qilu Hospital, Cheeloo College of Medicine, Shandong University, No. 107 West Wenhua Road, Jinan, 250012, Shandong, China.
Zhang N; Department of Geriatric Medicine and Shandong Key Laboratory of Cardiovascular Proteomics, Qilu Hospital, Cheeloo College of Medicine, Shandong University, No. 107 West Wenhua Road, Jinan, 250012, Shandong, China.
Li R; Department of Geriatric Medicine and Shandong Key Laboratory of Cardiovascular Proteomics, Qilu Hospital, Cheeloo College of Medicine, Shandong University, No. 107 West Wenhua Road, Jinan, 250012, Shandong, China.
Jiang W; Department of Geriatric Medicine and Shandong Key Laboratory of Cardiovascular Proteomics, Qilu Hospital, Cheeloo College of Medicine, Shandong University, No. 107 West Wenhua Road, Jinan, 250012, Shandong, China. .; Shandong Key Laboratory of Cardiovascular Proteomics, Qilu Hospital, Shandong University, Jinan, 250012, Shandong, China. .
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2022 Feb 25; Vol. 22 (1), pp. 67. Date of Electronic Publication: 2022 Feb 25.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Antipsychotic Agents*/therapeutic use
Basal Ganglia Diseases*
Multiple System Atrophy*/complications
Multiple System Atrophy*/diagnosis
Multiple System Atrophy*/drug therapy
Neuroleptic Malignant Syndrome*/diagnosis
Neuroleptic Malignant Syndrome*/etiology
Humans ; Levodopa/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical presentations and microbiological analysis of cerebrospinal fluid samples in cases of suspected bacterial meningitis patients attending a 1600 bedded teaching hospital from 2019 to 2022: A retrospective study.
Autorzy:
Kar, Mitra
Jamwal, Ashima
Dubey, Akanksha
Sahu, Chinmoy
Patel, Sangram Singh
Fatima, Nida
Pokaż więcej
Źródło:
Journal of Family Medicine & Primary Care. Sep2023, Vol. 12 Issue 9, p1893-1900. 8p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The diagnostic dilemma in a patient with neuroleptic malignant syndrome during the COVID‐19 pandemic: A significant increase in acute phase reactants.
Autorzy:
Elyasi, Forouzan (AUTHOR)
Zarghami, Mehran (AUTHOR)
Fariborzifar, Arghavan (AUTHOR)
Cheraghmakani, Hamed (AUTHOR)
Shirzad, Mahboobeh (AUTHOR)
Kazempour, Feteme (AUTHOR)
Pokaż więcej
Źródło:
Clinical Case Reports. Aug2023, Vol. 11 Issue 8, p1-8. 8p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A systematic review and pooled, patient-level analysis of predictors of mortality in neuroleptic malignant syndrome.
Autorzy:
Guinart D; Division of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, New York, NY, USA.; Center for Psychiatric Neuroscience, Feinstein Institutes for Medical Research, Manhasset, NY, USA.; Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Northwell/Hofstra, Hempstead, NY, USA.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Institut de Neuropsiquiatria i Addiccions (INAD), Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Departament de Psiquiatria, Universitat Autònoma de Barcelona, Barcelona, Spain.
Misawa F; Yamanashi Prefectural KITA Hospital, Yamanashi, Japan.
Rubio JM; Division of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, New York, NY, USA.; Center for Psychiatric Neuroscience, Feinstein Institutes for Medical Research, Manhasset, NY, USA.; Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Northwell/Hofstra, Hempstead, NY, USA.
Pereira J; Division of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, New York, NY, USA.
de Filippis R; Division of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, New York, NY, USA.; Psychiatry Unit, Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy.
Gastaldon C; Division of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, New York, NY, USA.; Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
Kane JM; Division of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, New York, NY, USA.; Center for Psychiatric Neuroscience, Feinstein Institutes for Medical Research, Manhasset, NY, USA.; Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Northwell/Hofstra, Hempstead, NY, USA.
Correll CU; Division of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, New York, NY, USA.; Center for Psychiatric Neuroscience, Feinstein Institutes for Medical Research, Manhasset, NY, USA.; Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Northwell/Hofstra, Hempstead, NY, USA.; Department of Child and Adolescent Psychiatry, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Pokaż więcej
Źródło:
Acta psychiatrica Scandinavica [Acta Psychiatr Scand] 2021 Oct; Vol. 144 (4), pp. 329-341. Date of Electronic Publication: 2021 Aug 25.
Typ publikacji:
Journal Article; Review; Systematic Review
MeSH Terms:
Antipsychotic Agents*/adverse effects
Neuroleptic Malignant Syndrome*/epidemiology
Neuroleptic Malignant Syndrome*/etiology
Adult ; Aged ; Humans ; Incidence ; Male ; Odds Ratio ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Malignant catatonia: Severity, treatment and outcome - a systematic case series analysis.
Autorzy:
Cronemeyer M; Department of Psychiatry and Psychotherapy III, University Hospital Ulm, Ulm, Germany.
Schönfeldt-Lecuona C; Department of Psychiatry and Psychotherapy III, University Hospital Ulm, Ulm, Germany.
Gahr M; Department of Psychiatry and Psychotherapy III, University Hospital Ulm, Ulm, Germany.
Keller F; Department of Child and Adolescent Psychiatry/Psychotherapy, University Hospital Ulm, Ulm, Germany.
Sartorius A; Department of Psychiatry and Psychotherapy, Central Institute of Mental Health (CIMH), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Pokaż więcej
Źródło:
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry [World J Biol Psychiatry] 2022 Jan; Vol. 23 (1), pp. 78-86. Date of Electronic Publication: 2021 Jun 10.
Typ publikacji:
Journal Article
MeSH Terms:
Catatonia*/diagnosis
Catatonia*/therapy
Electroconvulsive Therapy*
Neuroleptic Malignant Syndrome*
Benzodiazepines/therapeutic use ; Humans ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 7864

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies